Cite
HARVARD Citation
Yang, Y. et al. (2021). REBACIN® is an optional intervention for persistent high‐risk human papillomavirus infection: A retrospective analysis of 364 patients. International journal of gynaecology and obstetrics. 152 (1), pp. 82-87. [Online].